Enforced Expression of the Transcriptional Coactivator OBF1 Impairs B Cell Differentiation at the Earliest Stage of Development

被引:17
作者
Bordon, Alain [1 ]
Bosco, Nabil [2 ]
Du Roure, Camille [1 ]
Bartholdy, Boris [1 ]
Kohler, Hubertus [1 ]
Matthias, Gabriele [1 ]
Rolink, Antonius G. [2 ]
Matthias, Patrick [1 ]
机构
[1] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland
[2] Univ Basel, Dept Biomed, Div Dev Mol Immunol, CH-4003 Basel, Switzerland
关键词
D O I
10.1371/journal.pone.0004007
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
OBF1, also known as Bob. 1 or OCA-B, is a B lymphocyte-specific transcription factor which coactivates Oct1 and Oct2 on B cell specific promoters. So far, the function of OBF1 has been mainly identified in late stage B cell populations. The central defect of OBF1 deficient mice is a severely reduced immune response to T cell-dependent antigens and a lack of germinal center formation in the spleen. Relatively little is known about a potential function of OBF1 in developing B cells. Here we have generated transgenic mice overexpressing OBF1 in B cells under the control of the immunoglobulin heavy chain promoter and enhancer. Surprisingly, these mice have greatly reduced numbers of follicular B cells in the periphery and have a compromised immune response. Furthermore, B cell differentiation is impaired at an early stage in the bone marrow: a first block is observed during B cell commitment and a second differentiation block is seen at the large preB2 cell stage. The cells that succeed to escape the block and to differentiate into mature B cells have post-translationally downregulated the expression of transgene, indicating that expression of OBF1 beyond the normal level early in B cell development is deleterious. Transcriptome analysis identified genes deregulated in these mice and Id2 and Id3, two known negative regulators of B cell differentiation, were found to be upregulated in the EPLM and preB cells of the transgenic mice. Furthermore, the Id2 and Id3 promoters contain octamer-like sites, to which OBF1 can bind. These results provide evidence that tight regulation of OBF1 expression in early B cells is essential to allow efficient B lymphocyte differentiation.
引用
收藏
页数:16
相关论文
共 52 条
[1]  
[Anonymous], ATLAS CERAMBYCIDAE E
[2]   Frontline:: A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential [J].
Balciunaite, G ;
Ceredig, R ;
Massa, S ;
Rolink, AG .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) :2019-2030
[3]   A LYMPHOCYTE-SPECIFIC CELLULAR ENHANCER IS LOCATED DOWNSTREAM OF THE JOINING REGION IN IMMUNOGLOBULIN HEAVY-CHAIN GENES [J].
BANERJI, J ;
OLSON, L ;
SCHAFFNER, W .
CELL, 1983, 33 (03) :729-740
[4]   The Ets factor Spi-B is a direct critical target of the coactivator OBF-1 [J].
Bartholdy, Boris ;
Du Roure, Camille ;
Bordon, Alain ;
Emslie, Dianne ;
Corcoran, Lynn M. ;
Matthias, Patrick .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (31) :11665-11670
[5]   Regulation of BOB.1/OBF.1 stability by SIAH [J].
Boehm, J ;
He, YS ;
Greiner, A ;
Staudt, L ;
Wirth, T .
EMBO JOURNAL, 2001, 20 (15) :4153-4162
[6]   Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes [J].
Brunner, C ;
Laumen, H ;
Nielsen, PJ ;
Kraut, N ;
Wirth, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45231-45239
[7]   OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin κ genes [J].
Casellas, R ;
Jankovic, M ;
Meyer, G ;
Gazumyan, A ;
Luo, Y ;
Roeder, RG ;
Nussenzweig, MC .
CELL, 2002, 110 (05) :575-585
[8]   Increasing Flt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment [J].
Ceredig, Rhodri ;
Rauch, Melanie ;
Balciunaite, Gina ;
Rolink, Antonius G. .
BLOOD, 2006, 108 (04) :1216-1222
[9]   Differential requirement for OBF-1 during antibody-secreting cell differentiation [J].
Corcoran, LM ;
Hasbold, J ;
Dietrich, W ;
Hawkins, E ;
Kallies, A ;
Nutt, SL ;
Tarlinton, DM ;
Matthias, P ;
Hodgkin, PD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1385-1396
[10]   Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development [J].
Cotta, CV ;
Zhang, Z ;
Kim, HG ;
Klug, CA .
BLOOD, 2003, 101 (11) :4342-4346